TSX Venture Exchange Stock Maintenance Bulletins

VANCOUVER, BC, April 14, 2023

TSX VENTURE COMPANIES

BULLETIN TYPE:  Cease Trade Order
BULLETIN DATE:  April 14, 2023
TSX Venture Company

A Cease Trade Order has been issued by the by the Ontario and Quebec Securities Commissions on April 13, 2023, against the following Company for failing to file the document indicated within the required time period:

Symbol	Tier     Company	Failure to File ARIVA.DE Börsen-Geflüster Werbung Weiter aufwärts? Kurzfristig positionieren in John Deere Company VU6A9E Ask: 3,90 Hebel: 19,40 mit starkem Hebel Zum Produkt VU6NMW Ask: 8,52 Hebel: 4,74 mit moderatem Hebel Zum Produkt Vontobel Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: VU6A9E,VU6NMW,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen. Kurse CTO Realty Growth Inc. 17,80 $ -0,06% John Deere Company 397,02 $ +0,66% Navistar International -   0,00% Vanguard Russell 1000 ETF [Common Shares] 240,67 $ +0,15%	Period Ending (Y/M/D)
NHP	2      Lumiera Health Inc.	Annual Financial Statements	2022/11/30
		MD&A and Certification of Annual Filings	2022/11/30

Upon revocation of the Cease Trade Order, the Company's shares will remain suspended until the Company meets TSX Venture Exchange requirements. Members are prohibited from trading in the securities of the Company during the period of the suspension or until further notice.

TYPE DE BULLETIN : Interdiction d'opérations sur valeurs
DATE DU BULLETIN : Le 14 avril 2023
Société TSX Croissance

Une interdiction d'opérations sur valeurs a été émise le 13 avril 2023 par l'Autorité des marchés financiers envers la société suivante pour défaut de déposer le document indiqué dans la période prescrite :

Suite à l'interdiction d'opérations sur valeurs, la négociation des titres de la société demeurera suspendue jusqu'à ce que la société réponde aux normes de Bourse de croissance TSX. Il est interdit aux membres de transiger les titres de la société durant la période de suspension ou jusqu'à un avis ultérieur.

________________________________________

5D ACQUISITION CORP. ("FIVD.P")
BULLETIN TYPE:  Resume Trading
BULLETIN DATE:  April 14, 2023
TSX Venture Tier 2 Company

Further to TSX Venture Exchange bulletin dated April 12, 2023, effective at the open of market, April 18, 2023 shares of the Company will resume trading.

________________________________________

HAWKEYE GOLD & DIAMOND INC. ("HAWK")
BULLETIN TYPE:  Consolidation
BULLETIN DATE:  April 14, 2023
TSX Venture Tier 2 Company

Pursuant to a directors' resolution passed on March 24, 2023, the Company has consolidated its capital on a ten (10) old for one (1) new basis.  The name of the Company and the symbol of the Company has not been changed.

Effective at the opening April 18, 2023, the common shares of Hawkeye Gold & Diamond Inc. will commence trading on TSX Venture Exchange on a consolidated basis. The Company is classified as a 'Mining' company.

________________________________________

NAVCO PHARMACEUTICALS INC. ("NAV")
[formerly BMGB Capital Corp. ("BMGB.P")]
BULLETIN TYPE:  Qualifying Transaction-Completed/New Symbol, Property-Asset or Share Purchase Agreement, Private Placement-Non-Brokered, Name Change, Resume Trading
BULLETIN DATE:  April 14, 2023
TSX Venture Tier 2 Company

TSX Venture Exchange Inc. (the "Exchange") has accepted for filing the Qualifying Transaction of BMGB Capital Corp. (the "Company") (to be renamed NAVCO Pharmaceuticals Inc.) described in its filing statement dated November 28, 2022 (the "Filing Statement").  As a result, effective at the opening on Tuesday, April 18, 2023, the trading symbol for the Company will change from BMGB.P to NAV and the Company will no longer be considered a Capital Pool Company, thereafter the "Resulting Issuer".  The Qualifying Transaction includes the following matters, all of which have been accepted by the Exchange.

1.  Acquisition of all of the shares of NAVCO Pharmaceuticals Limited ("NAVCO")

Pursuant to a share exchange agreement dated as of January 18, 2021 among the Company, NAVCO and NAVCO shareholders, as amended, the Company acquired all of the issued and outstanding securities of NAVCO in consideration of the issuance of 21,340,000 common shares of the Company to the security holders of NAVCO.

NAVCO manufactures and researches nano-technology products and materials using Computerized Nano-meter Algorithms ("CAN"). These products have applications in the medical, textile, chemical and additive industries. NAVCO's products are tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats. NAVCO has three main product lines, namely, an aerosol spray, a cream and nano BioActive-Silver.

In connection with the Qualifying Transaction the Company issued 340,000 common shares to an arm's length finder as a finder's fee.

For further information, see the Filing Statement which is available under the Company's profile on SEDAR.

2.  Private Placement-Non-Brokered

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced December 1, 2022:

3.  Name Change

Pursuant to a resolution passed by directors of the Company on March 2, 2023 and the Certificate of Name Change dated April 11, 2023, the Company has changed its name from BMGB Capital Corp. to NAVCO Pharmaceuticals Inc.  There is no consolidation of share capital.

Effective at the opening on Tuesday, April 18, 2023, the common shares of NAVCO Pharmaceuticals Inc. will commence trading on TSX Venture Exchange, and the common shares of BMGB Capital Corp. will be delisted.

The Company is classified as a 'Life Sciences' company.

Capitalization:	Unlimited  shares with no par value of which
	40,350,441 shares are issued and outstanding
Escrow:	2,000,000  shares are subject to the CPC Escrow Agreement
	9,605,943  shares are subject to a 36 month staged release escrow agreement Werbung Mehr Nachrichten zur Navistar International Aktie kostenlos abonnieren E-Mail-Adresse Bitte überprüfe deine die E-Mail-Adresse. Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News 12:04 - PR Newswire Samson Rock Capital LLP - Disregard - Form 8.3 - abrdn Property Income Trust Limited 10:47 - PR Newswire TwentyFour Income Fund - Monthly Factsheet & Commentary - April 2024 08:44 - PR Newswire Invesco Global Equity Income Trust Plc - Director/PDMR Shareholding